047920 HLB제약
기본 정보
- 섹터: KOSDAQ:일반서비스
- 시가총액: 4,165억원 (2026-06-30 기준)
- 첫 등장: 2026-06-16 (누적 2일)
- 태그: 매크로/바이오헬스 · 매크로/소비미디어 · 전문의약품 · 신약 · DDS · 개량신약 · 건강기능식품
- 네이버 금융: 🔗
기업개요
- 동사는 1998년 씨트리로 설립되어 2020년 HLB그룹 편입과 함께 현 사명으로 변경하였으며, 2015년 코스닥시장에 상장함.
- 2025년 5월 신화어드밴스 지분 100%를 취득하여 의약품 유통 부문을 추가로 영위하고 있음.
- 전문의약품 제조·판매, 위수탁(CMO) 사업, 건강기능식품 판매를 주력으로 영위하며, 로수듀오, 씨트클러, 씨트렐린 등 160종 이상의 전문의약품을 위탁영업 방식으로 판매하고 있음.
출처: 네이버증권 종목분석 (WiseReport)
일자별 등장 (최신 위, 누적)
| 일자 | 전일 종가 | 종가 | 등락률 | 시간외 | vol | 색깔 | smart | 외 | 연 | 금투 | 투 | 개 | 그외 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | 8,740 | 8,800 | 🔴 +0.69% | +0.00%p | ×0.7 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | +0.0 | +0.0 | +0.6 | -0.1 |
| 2026-08-13 | 8,820 | 8,740 | 🔵 -0.91% | +0.22%p | ×0.4 | 🔻 개인 | -1.5억 | -1.5 | +0.0 | +0.0 | +0.0 | +1.6 | -0.1 |
| 2026-08-12 | 8,830 | 8,820 | 🔵 -0.11% | +0.34%p | ×0.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.0 | +0.0 | -0.2 | -0.0 |
| 2026-08-11 | 8,810 | 8,830 | 🔴 +0.23% | +0.00%p | ×0.4 | 🟢 외인 | +0.2억 | +0.2 | +0.0 | -0.0 | +0.0 | -0.0 | -0.2 |
| 2026-08-10 | 8,350 | 8,810 | 🔴 +5.51% | +0.84%p | ×0.6 | 🟢 외인 | +11.0억 | +11.0 | +0.0 | +0.0 | +0.0 | -11.1 | +0.1 |
| 2026-08-07 | 8,300 | 8,350 | 🔴 +0.60% | -0.48%p | ×0.3 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.0 | +0.5 | -0.1 |
| 2026-08-06 | 8,300 | 8,300 | ⚪ +0.00% | -0.24%p | ×0.3 | 🔻 개인 | -3.2억 | -3.2 | +0.0 | +0.0 | +0.0 | +3.6 | -0.4 |
| 2026-08-05 | 8,340 | 8,300 | 🔵 -0.48% | -0.96%p | ×0.3 | 🟢 외인 | +1.8억 | +1.8 | +0.0 | +0.0 | +0.0 | -1.7 | -0.1 |
| 2026-08-04 | 8,110 | 8,340 | 🔴 +2.84% | +1.24%p | ×0.4 | 🟢 외인 | +5.8억 | +5.8 | +0.0 | -0.0 | +0.0 | -6.1 | +0.3 |
| 2026-08-03 | 8,130 | 8,110 | 🔵 -0.25% | -2.10%p | ×0.4 | 🟢 외인 | +14.2억 | +14.2 | +0.0 | -0.0 | +0.0 | -13.5 | -0.7 |
| 2026-07-31 | 7,890 | 8,130 | 🔴 +3.04% | -0.26%p | ×0.2 | 🟢 외인 | +5.0억 | +5.0 | +0.0 | +0.0 | +0.0 | -5.0 | +0.1 |
| 2026-07-30 | 8,340 | 7,890 | 🔵 -5.40% | -0.48%p | ×0.3 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.3 | -0.0 |
| 2026-07-29 | 8,440 | 8,340 | 🔵 -1.18% | -1.30%p | ×0.5 | 🔻 개인 | +0.4억 | +0.4 | +0.0 | +0.0 | +0.0 | +2.0 | -2.4 |
| 2026-07-28 | 8,730 | 8,440 | 🔵 -3.32% | +1.15%p | ×0.3 | ⚫ 그외 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.0 | -1.9 | +2.3 |
| 2026-07-27 | 8,660 | 8,730 | 🔴 +0.81% | +1.27%p | ×0.4 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.1 | +0.0 | +0.6 | -0.1 |
| 2026-07-24 | 8,120 | 8,660 | ➖ 🔴 +6.65% | -4.43%p | ×3.6 | 🔻 개인 | -4.2억 | -4.2 | +0.0 | +0.1 | +0.0 | +3.1 | +1.0 |
| 2026-07-23 | 8,030 | 8,120 | 🔴 +1.12% | +0.62%p | ×0.5 | 🟢 외인 | +1.3억 | +1.3 | +0.0 | +0.0 | +0.0 | -0.9 | -0.4 |
| 2026-07-22 | 8,600 | 8,030 | 🔵 -6.63% | +0.35%p | ×1.0 | 🟢 외인 | +1.0억 | +1.0 | +0.0 | -0.0 | +0.0 | -1.0 | +0.1 |
| 2026-07-21 | 8,210 | 8,600 | 🔴 +4.75% | -0.85%p | ×2.0 | 🔻 개인 | -14.5억 | -14.5 | +0.0 | +0.0 | +0.0 | +14.1 | +0.4 |
| 2026-07-20 | 8,850 | 8,210 | 🔵 -7.23% | +1.70%p | ×1.2 | 🟢 외인 | +10.9억 | +10.9 | +0.0 | +0.0 | +0.0 | -10.5 | -0.3 |
| 2026-07-16 | 8,580 | 8,850 | 🔴 +3.15% | -6.06%p ⚠️ | ×10.3 | 🔻 개인 | -24.1억 | -24.1 | +0.0 | +0.0 | +0.0 | +22.8 | +1.2 |
| 2026-07-15 | 6,880 | 8,580 | 🔴 +24.71% | +0.00%p | ×2.6 | 🔻 개인 | -8.6억 | -8.6 | +0.0 | +0.0 | +0.0 | +9.0 | -0.4 |
| 2026-07-14 | 6,340 | 6,880 | 🔴 +8.52% | +4.42%p | ×4.0 | ⚫ 그외 | -0.2억 | -0.2 | +0.0 | +0.0 | +0.0 | -0.1 | +0.4 |
| 2026-07-13 | 8,570 | 6,340 | 🔵 -26.02% | +1.98%p | ×20.8 | 🟢 외인 | +6.3억 | +6.3 | +0.0 | -0.0 | +0.0 | +5.6 | -11.9 |
| 2026-07-10 | 12,330 | 8,570 | 🔵 -30.49% | +0.00%p | ×0.3 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | +0.0 | -0.1 | +0.0 |
| 2026-07-09 | 11,460 | 12,330 | 🔴 +7.59% | +0.78%p | ×1.3 | 🟢 외인 | +4.3억 | +4.3 | +0.0 | -0.0 | +0.0 | -3.8 | -0.4 |
| 2026-07-08 | 12,140 | 11,460 | 🔵 -5.60% | -0.58%p | ×0.6 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.0 | +0.8 | +0.0 |
| 2026-07-07 | 12,170 | 12,140 | 🔵 -0.25% | -0.25%p | ×0.7 | 🔻 개인 | -0.7억 | -0.7 | +0.0 | +0.0 | +0.0 | +0.6 | +0.1 |
| 2026-07-06 | 11,950 | 12,170 | 🔴 +1.84% | +0.75%p | ×0.5 | 🟢 외인 | +0.3억 | +0.3 | +0.0 | +0.0 | +0.0 | -0.4 | +0.1 |
| 2026-07-03 | 11,810 | 11,950 | 🔴 +1.70% | +1.62%p | ×0.3 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.0 | +0.4 | -0.0 |
| 2026-07-02 | 12,350 | 11,810 | 🔵 -4.37% | +0.49%p | ×0.4 | 🔻 개인 | -1.1억 | -1.1 | +0.0 | +0.0 | +0.0 | +0.8 | +0.3 |
| 2026-07-01 | 12,570 | 12,350 | 🔵 -1.75% | -0.48%p | ×0.3 | 🟣 투신 | -0.1억 | -0.2 | +0.0 | +0.0 | +0.1 | +0.0 | +0.0 |
| 2026-06-30 | 12,400 | 12,570 | 🔴 +1.37% | -1.05%p | ×0.3 | 🔻 개인 | -1.7억 | -1.7 | +0.0 | +0.0 | +0.0 | +1.7 | -0.0 |
| 2026-06-29 | 11,290 | 12,400 | 🔴 +9.83% | +0.97%p | ×0.4 | 🟢 외인 | +5.5억 | +5.5 | +0.0 | -0.0 | +0.0 | -5.3 | -0.1 |
| 2026-06-26 | 11,840 | 11,290 | 🔵 -4.65% | +0.67%p | ×0.4 | 🟢 외인 | +1.1억 | +1.1 | +0.0 | +0.0 | +0.0 | -1.2 | +0.1 |
| 2026-06-25 | 12,100 | 11,840 | 🔵 -2.15% | -0.25%p | ×0.3 | 🔻 개인 | -0.5억 | -0.5 | +0.0 | -0.0 | +0.0 | +0.7 | -0.2 |
| 2026-06-24 | 11,690 | 12,100 | 🔴 +3.51% | -0.85%p | ×0.2 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | -0.2 | +0.0 | |
| 2026-06-23 | 12,510 | 11,690 | 🔵 -6.55% | -1.51%p | ×0.6 | 🟢 외인 | +1.6억 | +1.6 | +0.0 | -0.0 | -1.5 | -0.1 | |
| 2026-06-22 | 12,130 | 12,510 | 🔴 +3.13% | -1.65%p | ×0.4 | 🔻 개인 | -0.2억 | -0.2 | +0.0 | -0.0 | +0.4 | -0.2 | |
| 2026-06-19 | 13,000 | 12,130 | 🔵 -6.69% | -0.38%p | ×0.7 | 🟢 외인 | +2.1억 | +2.1 | +0.0 | -0.1 | -2.0 | +0.0 | |
| 2026-06-18 | 13,370 | 13,000 | 🔵 -2.77% | +0.52%p | ×1.0 | 🔻 개인 | -10.6억 | -10.6 | +0.0 | +0.0 | +10.7 | -0.1 | |
| 2026-06-17 | 12,140 | 13,370 | ➕ 🔴 +10.13% | +1.89%p | ×2.9 | 🟢 외인 | +4.5억 | +4.5 | +0.0 | -0.0 | -6.4 | +1.9 | |
| 2026-06-16 | 11,010 | 12,140 | ➕ 🔴 +10.26% | +0.90%p | ×8.2 | 🔻 개인 | -20.7억 | -20.7 | +0.0 | -0.0 | +21.1 | -0.4 | |
| 2026-06-15 | 10,930 | 11,010 | 🔴 +0.73% | +0.46%p | ×0.6 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | -0.7 | +1.2 | -0.1 | |
| 2026-06-12 | 10,880 | 10,930 | 🔴 +0.46% | -0.28%p | ×0.7 | 🟢 외인 | +3.2억 | +3.2 | +0.0 | -0.0 | -3.6 | +0.5 | |
| 2026-06-11 | 10,940 | 10,880 | 🔵 -0.55% | +1.55%p | ×0.9 | 🔻 개인 | -0.8억 | -0.8 | +0.0 | +0.0 | +0.6 | +0.3 | |
| 2026-06-10 | 11,070 | 10,940 | 🔵 -1.17% | -1.26%p | ×0.5 | 🔻 개인 | -0.4억 | -0.4 | +0.0 | +0.0 | +0.5 | -0.1 | |
| 2026-06-09 | 10,690 | 11,070 | 🔴 +3.55% | +0.84%p | ×0.4 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | +0.0 | -0.0 | -0.1 | |
| 2026-06-08 | 11,380 | 10,690 | 🔵 -6.06% | -0.96%p | ×0.5 | 🟢 외인 | +1.7억 | +1.7 | +0.0 | +0.0 | -1.7 | +0.0 | |
| 2026-06-05 | 11,460 | 11,380 | 🔵 -0.70% | +0.70%p | ×0.5 | 🟢 외인 | +2.2억 | +2.2 | +0.0 | +0.0 | -2.3 | +0.0 | |
| 2026-06-04 | 11,640 | 11,460 | 🔵 -1.55% | -1.21%p | ×0.3 | 🟢 외인 | +0.1억 | +0.1 | +0.0 | -0.0 | -0.2 | +0.1 | |
| 2026-06-02 | 12,140 | 11,640 | 🔵 -4.12% | +0.25%p | ×1.1 | 🟢 외인 | +7.8억 | +7.8 | +0.0 | -1.3 | -9.5 | +2.9 | |
| 2026-06-01 | 12,660 | 12,140 | 🔵 -4.11% | +0.00%p | ×1.1 | 🟡 금투 | -0.5억 | -0.5 | +0.0 | +0.6 | -0.3 | +0.2 | |
| 2026-05-29 | 12,400 | 12,660 | ⚡ 🔴 +2.10% | +7.02%p ⚡ | ×1.0 | 🔻 개인 | -4.6억 | -4.6 | +0.0 | -0.0 | +4.6 | +0.0 | |
| 2026-05-28 | 12,690 | 12,400 | 🔵 -2.29% | -0.24%p | ×0.6 | 🔻 개인 | -1.0억 | -1.0 | +0.0 | -0.0 | +1.5 | -0.5 | |
| 2026-05-27 | 13,260 | 12,690 | 🔵 -4.30% | +0.38%p | ×1.0 | 🟢 외인 | +0.8억 | +0.8 | +0.0 | -0.0 | -0.8 | +0.1 | |
| 2026-05-26 | 13,350 | 13,260 | 🔵 -0.67% | +1.20%p | ×1.0 | 🔻 개인 | -3.3억 | -3.3 | +0.0 | -0.0 | +3.8 | -0.5 | |
| 2026-05-22 | 12,440 | 13,350 | 🔴 +7.32% | +1.53%p | ×1.8 | 🟢 외인 | +7.0억 | +7.0 | +0.0 | +0.3 | -9.0 | +1.7 |
일자별 사유 (최신 위)
2026-07-24
- 사유: 담도암치료제 9월 FDA 허가 기대, HLB그룹주 동반 강세
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +235억)
- 매크로 원인: HLB 담도암 FDA 허가 기대에 진단·AI신약·비만약 등 바이오헬스 개별 호재 겹쳐 동반 강세 (보통)
2026-07-15
- 사유: HLB 그룹주 동반 상한가
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +166억)
- 매크로 원인: HLB 리보세라닙 FDA 제조 리스크 해소 기대에 그룹주 무더기 상한가, 미프진 허가 검토·항암신약 모멘텀 가세 (보통)
2026-06-17
- 사유: 바이오주 반등 흐름 동참
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart +109억)
- 매크로 원인: 바이오 USA 개막발 기술이전 기대 + FDA·임상 호재로 소외됐던 제약바이오 일제 반등 (보통)
2026-06-16
- 사유: 자회사 이뮤노믹 日 임상1상 승인+HLB그룹 인력 영입
- 섹터 컨텍스트: KOSDAQ:일반서비스 (smart -137억)
- 매크로 원인: 유전자치료·교정 바이오 개별 모멘텀(무증·임상·공시) 산발, 외국인 사흘째 매수로 코스피 반등 동조 (보통)